WASHINGTON - An experimental drug from Swiss pharma giant Novartis reduced deaths from chronic heart failure by 20 per cent compared with an existing treatment, according to the results of a vast new study.
from NationMultimedia.com - Breakingnews http://ift.tt/1lpt2He
via IFTTT
from NationMultimedia.com - Breakingnews http://ift.tt/1lpt2He
via IFTTT
0 件のコメント:
コメントを投稿